WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.7% of their position (1.10K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $1.7K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/18/2023ACC: 0001213900-23-096606
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+1.10K
Net shares
Net buyer
$1.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.10K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+200.00
Price / share
$1.50
Trade value
$300.00
% of position
0.1%
12/14/2023
168.12K→168.32K
Common Stock
Direct
Shares
+900.00
Price / share
$1.52
Trade value
$1.37K
% of position
0.5%
12/15/2023
168.32K→169.22K
Total
Net shares
+1.10K
Net value
$1.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/14/2023 | P · Purchase | +200.00 | $1.50 | $300.00 | 0.1% | 168.12K | 168.32K |
| Common Stock Direct | 12/15/2023 | P · Purchase | +900.00 | $1.52 | $1.37K | 0.5% | 168.32K | 169.22K |
| Total | +1.10K | $1.67K | ||||||
Derivative Transactions0
No derivative transactions reported